
1. j exp med. 2008 feb 18;205(2):395-408. doi: 10.1084/jem.20071548. epub 2008 jan
28.

inhibition histamine-mediated signaling confers significant protection against
severe malaria mouse models disease.

beghdadi w(1), porcherie a, schneider bs, dubayle d, peronet r, huerre m,
watanabe t, ohtsu h, louis j, mécheri s.

author information: 
(1)unité des réponses précoces aux parasites et immunopathologie, institut
pasteur, paris 75015, france.

from inoculation plasmodium sporozoites via anopheles mosquito bites to
the development blood-stage parasites, hallmark host response an
inflammatory reaction characterized elevated histamine levels serum and
tissues. given proinflammatory immunosuppressive activities associated
with histamine, postulated vasoactive amine participates malaria 
pathogenesis. combined genetic pharmacologic approaches demonstrated that
histamine binding h1r h2r h3r h4r increases susceptibility
of mice infection plasmodium. understand role histamine
in malaria pathogenesis, used histidine decarboxylase-deficient (hdc(-/-))
mice, free histamine. hdc(-/-) mice highly resistant severe 
malaria whether infected mosquito bites via injection infected
erythrocytes. hdc(-/-) mice displayed resistance two lethal strains:
plasmodium berghei (pb) anka, triggers cerebral malaria (cm), pb nk65, 
which causes death without neurological symptoms. resistance hdc(-/-) mice
to cm associated preserved blood-brain barrier integrity, absence of
infected erythrocyte aggregation brain vessels, lack of
sequestration cd4 cd8 cells. demonstrate histamine-mediated
signaling contributes malaria pathogenesis. understanding basis 
biological effects histamine infection may lead novel therapeutic
strategies alleviate severity malaria.

doi: 10.1084/jem.20071548 
pmcid: pmc2271011
pmid: 18227221  [indexed medline]

